Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exagen Inc. - Common Stock (NQ:XGN)

4.410 -0.620 (-12.33%)
Delayed Quote Updated: 4:00 PM EST, Nov 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exagen Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Exagen (XGN) Q3 2026 Earnings Call Transcript ↗
Management outlined new product launches and an AI acquisition aimed at deeper clinic integration. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
What Exagen (XGN) Said on Its Q3 Earnings Call ↗
Exagen (NASDAQ:XGN) reported third-quarter revenue of $18.4 million, up 7% from a year earlier, as higher test volume and pricing helped the autoimmune diagnostics company post what management... 
Via MarketBeat
Topics Earnings
News headline image
Exagen Inc. Reports Third Quarter 2026 Financial Results
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Upcoming Investor Conferences
From Exagen Inc.
Via GlobeNewswire
Exagen (NASDAQ:XGN) Beats Q2 Estimates and Raises Full-Year Guidance ↗
Via Chartmill
Exagen Inc. (NASDAQ:XGN) Soars on Q1 2026 Earnings Beat as Record Revenue and Narrowed Loss Fuel Pre-Market Rally ↗
Via Chartmill
Topics Earnings
Exagen Inc. (NASDAQ:XGN) Reports Record 2025 Revenue and Provides 2026 Outlook ↗
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Exagen to Announce Third Quarter Financial Results on November 10, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen (XGN) Q2 2026 Earnings Call Transcript ↗
Record revenue and near break-even adjusted EBITDA signal progress toward profitability. 
Via The Motley Fool
Topics Earnings Economy
News headline image
Exagen Q2 Earnings Call Highlights ↗
Exagen (NASDAQ:XGN) reported record second-quarter revenue as growth in AVISE CTD test volume, average selling price and Pharma Services revenue brought the autoimmune diagnostics company close to... 
Via MarketBeat
Topics Artificial Intelligence Earnings
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Top movers in Tuesday's session ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Exagen Inc. Reports Second Quarter 2026 Financial Results
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Upcoming Investor Conference
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen to Announce Second Quarter Financial Results on August 4, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen (XGN) Q1 2026 Earnings Transcript ↗
Exagen (XGN) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Exagen Q1 Earnings Call Highlights ↗
Exagen (NASDAQ:XGN) reported record first-quarter revenue and reaffirmed its full-year outlook, as executives said growth in testing volume, improved reimbursement execution and expanding clinician... 
Via MarketBeat
Topics Earnings
News headline image
Exagen Inc. Reports First Quarter 2026 Results
Delivers record total revenue and AVISE(R) CTD average selling price 
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Upcoming Investor Conferences
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. Announces Select Preliminary 2025 Financial Results
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. (NASDAQ:XGN) Reports Mixed Q3 2025 Results with Revenue Beat and Wider-Than-Expected Loss ↗
Exagen's Q3 2025 results show a revenue beat but a wider-than-expected loss, causing a pre-market stock decline. 
Via Chartmill
News headline image
Exagen Inc. Reports Strong Q3 2025 Results
From Exagen Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.